4th Quarter - Amendment — EPILEPSY FOUNDATION for EPILEPSY FOUNDATION (2008)

Firm

EPILEPSY FOUNDATION

Client

EPILEPSY FOUNDATION

Income

—

Expenses

$30,000

Expense method

B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
4th Quarter - Report	Nov 19, 2008	$100,000	Replaced
4th Quarter - Report	Jan 21, 2009	$30,000	Replaced
4th Quarter - Amendment (this page)	Apr 21, 2009	$30,000	Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

H.R. 2128 - Epilepsy Centers for Excellence Act of 2007 S. 204 - Epilepsy Centers of Excellence Act of 2007

Lobbyist	Covered position, as disclosed
DONNA MELTZER	Senior Government Relations Director
ANGELA OSTROM	Director, Federal Relations

Contacted: HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); White House Office

Bills named: H.R. 2128 (110th), S. 204 (110th)

Budget/Appropriations BUD

Labor, HHS, Education and Related Agencies on epilepsy and health issues. Appropriations for NIH, CDCP amd HRSA and funding for the Lifespan Respite Act Research funding for epilepsy, Sought report language on Prescription Drug Access Issues in the Agriculture Rural Development, FDA and Related Issues Appropriation bill

Lobbyist	Covered position, as disclosed
DONNA MELTZER	Senior Government Relations Director
ANGELA OSTROM	Director, Federal Relations

Contacted: Veterans Affairs, Dept of (VA); White House Office; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Medicare and Medicaid Related Issues and Prescription Drug Policy Medicare Policy Reform Prescription Drug Access Issues

Lobbyist	Covered position, as disclosed
DONNA MELTZER	Senior Government Relations Director
ANGELA OSTROM	Director, Federal Relations

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Veterans Affairs, Dept of (VA); Health Resources & Services Administration (HRSA); White House Office; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.